Emerging role of intensity-modulated radiation therapy in anorectal cancer

References

• No authors listed. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet348, 1605–1610 (1996).
   PubMed Web of Science ®Google Scholar
• Fisher B, Wolmark N, Rockette H et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J. Natl Cancer Inst.80, 21–29 (1988).
   PubMed Web of Science ®Google Scholar
• Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N. Engl. J. Med.312, 1465–1472 (1985).
   PubMed Web of Science ®Google Scholar
• Krook JE, Moertel CG, Gunderson LL et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med.324, 709–715 (1991).
   PubMed Web of Science ®Google Scholar
• Nigro N, Vaitkevicius V, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis. Colon Rectum17, 354–356 (1974).
   PubMed Web of Science ®Google Scholar
• Flam M, John M, Pajak TF et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a Phase III randomized intergroup study. J. Clin. Oncol.14, 2527–2539 (1996).
   PubMed Web of Science ®Google Scholar
• Bartelink H, Roelofsen F, Eschwege F et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a Phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J. Clin. Oncol.15, 2040–2049 (1997).
   PubMed Web of Science ®Google Scholar
• Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet14, 2527–2539 (1996).
   Google Scholar
• Ajani J, Winter K, Gunderson L et al. Intergroup RTOG 98–11: a Phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin, and radiotherapy in carcinoma of the anal canal. Proc. Am. Soc. Clin. Oncol.24, S18 (2006).
   Google Scholar
• Bortfeld T, Boyer AL, Schlegel W et al. Realization and verification of three-dimensional conformal radiotherapy with modulated fields. Int. J. Radiat. Oncol. Biol. Phys.30, 899–908 (1994).
   PubMed Web of Science ®Google Scholar
• Burman C, Chui CS, Kutcher G et al. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys.39, 863–873 (1997).
   PubMed Web of Science ®Google Scholar
• Stein J, Bortfeld T, Dorschel B et al. Dynamic x-ray compensation for conformal radiotherapy by means of multi-leaf collimation. Radiother. Oncol.32, 163–173 (1994).
   PubMedGoogle Scholar
• Trautmann TG, Zuger JH. Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. Mol. Imaging Biol.7, 309–313 (2005).
   PubMedGoogle Scholar
• Cotter SE, Grigsby PW, Siegel BA et al. FDG-PET/CT in the evaluation of anal carcinoma. Int. J. Radiat. Oncol. Biol. Phys.65, 720–725 (2006).
   PubMedGoogle Scholar
• Anderson C, Koshy M, Staley C et al. PET-CT fusion in radiation management of patients with anorectal tumors. Int. J. Radiat. Oncol. Biol. Phys.69, 155–162 (2007).
   PubMedGoogle Scholar
• Letourneau D, Martinez AA, Lockman D et al. Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int. J. Radiat. Oncol. Biol. Phys.62, 1239–1246 (2005).
   PubMed Web of Science ®Google Scholar
• Godfrey DJ, Yin FF, Oldham M et al. Digital tomosynthesis with an on-board kilovoltage imaging device. Int. J. Radiat. Oncol. Biol. Phys.65, 8–15 (2006).
   PubMedGoogle Scholar
• Gao S, Zhang L, Wang H et al. A deformable image registration method to handle distended rectums in prostate cancer radiotherapy. Med. Phys.33, 3304–3312 (2006).
   PubMed Web of Science ®Google Scholar
• de Crevoisier R, Melancon AD, Kuban DA et al. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys.68, 1529–1536 (2007).
   PubMedGoogle Scholar
• Nuyttens JJ, Robertson JM, Yan D et al. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int. J. Radiat. Oncol. Biol. Phys.53, 497–503 (2002).
   PubMed Web of Science ®Google Scholar
• Kupelian PA, Langen KM, Zeidan OA et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys.66, 876–882 (2006).
   PubMedGoogle Scholar
• Yin FF, Das S, Kirkpatrick J et al. Physics and imaging for targeting of oligometastases. Semin. Radiat. Oncol.16, 85–101 (2006).
   PubMedGoogle Scholar
• Yan D, Lockman D, Martinez A et al. Computed tomography guided management of interfractional patient variation. Semin. Radiat. Oncol.15, 168–179 (2005).
   PubMed Web of Science ®Google Scholar
• Hartley A, Ho KF, McConkey C et al. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of Phase II/III trials. Br. J. Radiol.78, 934–938 (2005).
   PubMed Web of Science ®Google Scholar
• Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med.351, 1731–1740 (2004).
   PubMed Web of Science ®Google Scholar
• Habr-Gama A, Perez RO, Proscurshim I et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J. Gastrointest. Surg.10, 1319–1328 (2006).
   PubMed Web of Science ®Google Scholar
• Wiltshire KL, Ward IG, Swallow C et al. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int. J. Radiat. Oncol. Biol. Phys.64, 709–716 (2006).
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, Regine WF, John WJ et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int. J. Radiat. Oncol. Biol. Phys.46, 883–888 (2000).
   PubMed Web of Science ®Google Scholar
• Overgaard M, Overgaard J, Sell A. Dose-response relationship for radiation therapy of recurrent, residual, and primarily inoperable colorectal cancer. Radiother. Oncol.1, 217–225 (1984).
   PubMedGoogle Scholar
• Papillon J, Montbarbon JF, Gerard JP et al. Interstitial curietherapy in the conservative treatment of anal and rectal cancers. Int. J. Radiat. Oncol. Biol. Phys.17, 1161–1169 (1989).
   PubMed Web of Science ®Google Scholar
• John M, Pajak T, Flam M et al. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92–08. Cancer J. Sci. Am.2, 205–211 (1996).
   PubMedGoogle Scholar
• Constantinou EC, Daly W, Fung CY et al. Time-dose considerations in the treatment of anal cancer. Int. J. Radiat. Oncol. Biol. Phys.39, 651–657 (1997).
   PubMedGoogle Scholar
• Huang K, Haas-Kogan D, Weinberg V et al. Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal. World J. Gastroenterol.13, 895–900 (2007).
   PubMed Web of Science ®Google Scholar
• Deniaud-Alexandre E, Touboul E, Tiret E et al. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int. J. Radiat. Oncol. Biol. Phys.56, 1259–1273 (2003).
   PubMed Web of Science ®Google Scholar
• Chapet O, Gerard JP, Riche B et al. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int. J. Radiat. Oncol. Biol. Phys.63, 1316–1324 (2005).
   PubMed Web of Science ®Google Scholar
• Nguyen NP, Antoine JE, Dutta S et al. Current concepts in radiation enteritis and implications for future clinical trials. Cancer95, 1151–1163 (2002).
   PubMed Web of Science ®Google Scholar
• Eifel PJ, Levenback C, Wharton JT et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys.32, 1289–1300 (1995).
   PubMed Web of Science ®Google Scholar
• Potish RA, Jones TK Jr, Levitt SH. Factors predisposing to radiation-related small-bowel damage. Radiology132, 479–482 (1979).
   PubMed Web of Science ®Google Scholar
• Rotman M, Moon S, John M et al. Extended field para-aortic radiation in cervical carcinoma: the case for prophylactic treatment. Int. J. Radiat. Oncol. Biol. Phys.4, 795–799 (1978).
   PubMed Web of Science ®Google Scholar
• Baglan KL, Frazier RC, Yan D et al. The dose–volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys.52, 176–183 (2002).
   PubMed Web of Science ®Google Scholar
• Tho LM, Glegg M, Paterson J et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. Int. J. Radiat. Oncol. Biol. Phys.66, 505–513 (2006).
   PubMed Web of Science ®Google Scholar
• Gunnlaugsson A, Kjellen E, Nilsson P et al. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol.46, 937–944 (2007).
   PubMed Web of Science ®Google Scholar
• Ryan DP, Niedzwiecki D, Hollis D et al. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J. Clin. Oncol.24, 2557–2562 (2006).
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, Winter K, Mitchell E et al. Randomized Phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J. Clin. Oncol.24, 650–655 (2006).
   PubMed Web of Science ®Google Scholar
• Czito BG, Willett CG, Bendell JC et al. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: Phase I trial results. J. Clin. Oncol.24, 656–662 (2006).
   PubMed Web of Science ®Google Scholar
• Ashman JB, Zelefsky MJ, Hunt MS et al. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.63, 765–771 (2005).
   PubMed Web of Science ®Google Scholar
• Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int. J. Radiat. Oncol. Biol. Phys.56, 1354–1360 (2003).
   PubMed Web of Science ®Google Scholar
• Guerrero Urbano MT, Henrys AJ, Adams EJ et al. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int. J. Radiat. Oncol. Biol. Phys.65, 907–916 (2006).
   PubMedGoogle Scholar
• Duthoy W, De Gersem W, Vergote K et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys.60, 794–806 (2004).
   PubMed Web of Science ®Google Scholar
• Salama JK, Mell LK, Schomas DA et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J. Clin. Oncol.25, 4581–4586 (2007).
   PubMed Web of Science ®Google Scholar
• Miller CW. Survival and ambulation following hip fracture. J. Bone Joint Surg. Am.60, 930–934 (1978).
   PubMed Web of Science ®Google Scholar
• Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet359, 1761–1767 (2002).
   PubMed Web of Science ®Google Scholar
• Martenson JA Jr, Gunderson LL. External radiation therapy without chemotherapy in the management of anal cancer. Cancer71, 1736–1740 (1993).
   PubMed Web of Science ®Google Scholar
• Baxter NN, Habermann EB, Tepper JE et al. Risk of pelvic fractures in older women following pelvic irradiation. JAMA294, 2587–2593 (2005).
   PubMed Web of Science ®Google Scholar
• Chen YJ, Liu A, Tsai PT et al. Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. Int. J. Radiat. Oncol. Biol. Phys.63, 274–281 (2005).
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A et al. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys.21, 109–122 (1991).
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Fuks Z, Hunt M et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int. J. Radiat. Oncol. Biol. Phys.53, 1111–1116 (2002).
   PubMed Web of Science ®Google Scholar
• Mell LK, Schomas DA, Salama JK et al. Associated between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. (2007) (Epub ahead of print).
   Google Scholar